Surveillance of tick-borne encephalitis in emerging risk areas in southern Sweden: a retrospective case finding study.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 02 05 2022
accepted: 11 10 2022
pubmed: 3 11 2022
medline: 10 1 2023
entrez: 2 11 2022
Statut: ppublish

Résumé

Tick-borne encephalitis (TBE) is an emerging infection causing CNS infection of various severity. Good knowledge of the incidence in the population and defined risk areas is important in risk communication and vaccination recommendations. The aim of this study was to investigate potential underreporting by retrospectively diagnose TBE among patients with viral CNS infections of unknown etiology in a region with emerging risk areas for TBE, and define variables associated with performed TBE serology at the time of infection. Epidemiological data and microbiological diagnostics of cases with viral CNS infection of unknown etiology treated at departments of infectious diseases and pediatrics in Skåne County during 2000-2012 were investigated. Analyses to evaluate variables associated with performed TBE serology at the time of infection were performed. Retrospective TBE serology was performed on stored blood samples when available. TBE serology was already performed at the time of CNS infection in 193 out of 761 cases. Department, type of clinical manifestation, time period of illness, and whether Borrelia serology had been performed were independent variables associated with having had TBE serology performed or not at the time of illness. Only one of 137 cases, where samples could be retrospectively analyzed for TBE, turned out positive. This study shows a low frequency of TBE sampling among patients with meningoencephalitis in a region with emerging risk for TBE. A higher awareness of TBE as differential diagnosis could contribute to earlier detection of new risk areas and adequate preventive advice to the public.

Identifiants

pubmed: 36322256
doi: 10.1007/s10096-022-04509-1
pii: 10.1007/s10096-022-04509-1
pmc: PMC9816246
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-22

Informations de copyright

© 2022. The Author(s).

Références

Neurology. 2006 Jan 10;66(1):75-80
pubmed: 16401850
Vaccine. 2003 Apr 1;21 Suppl 1:S66-72
pubmed: 12628817
Scand J Infect Dis. 1990;22(3):287-95
pubmed: 2371544
Lancet. 2008 May 31;371(9627):1861-71
pubmed: 18514730
Euro Surveill. 2017 Mar 16;22(11):
pubmed: 28333618
Scand J Infect Dis. 2006;38(9):800-4
pubmed: 16938735
Lancet Infect Dis. 2018 Sep;18(9):992-1003
pubmed: 30153934
Euro Surveill. 2009 Sep 10;14(36):
pubmed: 19758543
Acta Med Scand. 1959 Aug 31;164:507-22
pubmed: 14402807
Clin Infect Dis. 2002 Sep 15;35(6):650-8
pubmed: 12203160
J Med Virol. 2013 Mar;85(3):554-62
pubmed: 23239485
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721541
Lakartidningen. 2002 May 23;99(21):2380-1
pubmed: 12090163
Euro Surveill. 2015;20(37):
pubmed: 26535471
Parasit Vectors. 2014 Mar 11;7:102
pubmed: 24618209
Euro Surveill. 2011 Sep 29;16(39):
pubmed: 21968422
Eur J Neurol. 2017 Aug;24(8):1062-1070
pubmed: 28636287
Euro Surveill. 2015;20(40):
pubmed: 26537646
Ticks Tick Borne Dis. 2018 May;9(4):956-962
pubmed: 29610047
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256
Pathogens. 2019 Mar 29;8(2):
pubmed: 30934855

Auteurs

Mattias Waldeck (M)

Regional Office of Communicable Disease Control and Prevention, Malmö, Region Skåne, Sweden. Mattias.Waldeck@skane.se.
Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Mattias.Waldeck@skane.se.
Department of Infectious Diseases, Central Hospital Kristianstad, Kristianstad, Sweden. Mattias.Waldeck@skane.se.

Niclas Winqvist (N)

Regional Office of Communicable Disease Control and Prevention, Malmö, Region Skåne, Sweden.
Clinical Infection Medicine, Department of Translational Medicine, Lund University, Lund, Sweden.

Gunnel Henriksson (G)

Department of Clinical Microbiology, Skåne University Hospital, Lund, Sweden.
Department of Laboratory Medicine, Division of Medical Microbiology, Lund University, Lund, Sweden.

Robert Dyrdak (R)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Bo Settergren (B)

Department of Infectious Diseases, Central Hospital Kristianstad, Kristianstad, Sweden.

Per-Eric Lindgren (PE)

Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Clinical Microbiology, Laboratory Medicine, County Hospital Ryhov, Jönköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH